300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Beauty
Fashion
Medical
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Web3
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Recruiting
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Tunisia
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Taiwan
Zimbabwe
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Ghana
Denmark
Georgia
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Kenya
Saudi Arabia
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Hungary
Italy
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Device of Tomorrow Capital

VC Fund

Anaheim, United States

Device of Tomorrow Capital is a VC fund in Anaheim focused on Health Care and Medical Device. Device of Tomorrow Capital

Total investments:
11
Last investment:
Lead investor:
9%

Last updated:

Industries Device of Tomorrow Capital invests in

Health CareMedical DeviceMedicalBiotechnologyManufacturing

Stages Device of Tomorrow Capital invests in

SeedSeries ASeries BPre-Seed

Countries Device of Tomorrow Capital invests in

United StatesUnited Kingdom

Investment Focus

Industry

  • Health Care 9 (82%)
  • Medical Device 6 (55%)
  • Medical 5 (45%)
  • Biotechnology 2 (18%)
  • Manufacturing 2 (18%)
See all 15 industries →

Stage

  • Seed 5 (45%)
  • Series A 3 (27%)
  • Series B 2 (18%)
  • Pre-Seed 1 (9%)

Country

  • United States 10 (91%)
  • United Kingdom 1 (9%)

Investments

CompanyDescriptionRoundLinks
WearLinq WearLinq
WearLinq is a provider of wearable health monitoring and diagnosis solutions. The company's device records a multi-lead ECG and transmits it in real-time with AI to detect typical irregular heart rhythms, including a normal heart rhythm, aFib, bradycardia, and tachycardia, allowing users to discover history and trends, set reminders, andconnect directly with physicians. $14M / Series A / Dec 17, 2025
Laplace Labs Laplace Labs
A Game Changing AI native productivity operation system, more flexible and smarter $500K / Pre-Seed / Oct 01, 2023
Identical Identical
Identical is a developer of personalized dental implants used to make tooth replacement more accessible and affordable for everyone. Its implants are drill-free and non-invasive and use the latest 3D technology that enables dentists to deliver personalized dental implants in a faster and safer way.It was founded in 2018 and is headquartered inWalnut Creek, California. Seed / Jan 24, 2023
Paloma Health Paloma Health
Paloma Health is the first online medical practice dedicated to transforming care for hypothyroidism. The HealthTech company offers a best-in-class experience for the 25 million Americans that struggle with the highly impactful chronic condition and are dissatisfied with the quality and convenience of their care.Paloma Health makes it easy toget expert, personalized treatment for hypothyroidism––all from the comfort of home. Delivered via telemedicine by expert, caring doctors and nutritionists, the company combines evidence-based treatment approaches with at-home lab testing to deliver the best care and experience available. Series A / Jan 23, 2023
Telesair Telesair
Telesair is a medical device company in stealth mode that is developing breakthrough respiratory care solutions to move patients from the hospital to home sooner. Their solutions elevate the existing standard of care by enhancing outcomes for patients and the health system. $22M / Series A / Jan 10, 2023
CARI Health CARI Health
Cari Health develops remote medication monitors that allow clinicians to prescribe medications and receive real-time reporting on medication levels. Its monitors are wireless sensors that are worn on the patient's skin and continuously send data about medication levels to the cloud.The company was founded in 2015, incorporated in 2021 and isheadquartered in San Diego, California. $2.3M / Seed / Jan 10, 2023
Eximius Diagnostics Eximius Diagnostics
Eximius Diagnostics is a developer of non-invasive extracellular vesicles to detect early-stage liver cancer with nano-exosomes. Its non-invasive extracellular vesicles are based on in vitro diagnostics test and specialize in developing platform technologies for the purification and characterization of tumor-derived conditions from serum andplasma. Seed / Jan 01, 2023
Centerline Biomedical Centerline Biomedical
Centerline Biomedical, Inc. was founded in November 2014 and is based on technology developed at the Cleveland Clinic. Centerline's mission is to develop advanced navigation systems that initially target interventional vascular procedures. $33M / Series B / Jun 27, 2022
Smartlens Smartlens
Smartlens is a clinical-stage Med Tech company with a portfolio of technologies to treat and diagnose Glaucoma - a chronic eye disease and the leading cause of irreversible blindness. The Company is running clinical trials with its novel eye pressure (IOP) monitoring contact lens (miLens) that will help improve clinical outcomes in Glaucoma. Thedisease affects hundreds of millions around the globe; even in developed countries more than 50% of the patients are currently undiagnosed, and more than 38% are going blind despite being treated. The need for monitoring eye pressure outside the clinic has been defined as an urgent need by scientific, medical, and industry leaders in ophthalmology that will help improve clinical outcomes. Smartlens’ flagship product miLens is a non-invasive and convenient way of monitoring eye pressure for anyone anywhere at any time. It will help improve early diagnosis, enable personalized treatments, and disease monitoring thus reducing the prevalence of blindness, treatment costs, and its huge burden on lives and economies. miLens is utilizing a novel, electronics-free sensor technology that is fully owned by Smartlens, Inc. and protected by its portfolio of issued and pending patents covering more than 40 countries. The Company's novel technology is also being studied at Stanford University Labs for monitoring (ICP) which is associated with certain neurological disorders, and cancers. Smartlens also owns a non-invasive drug delivery technology that monitors the IOP and releases the right medication at the right time which will help improve efficacy, patient compliance and reduce the side effects. Smartlens is the Winner of the 2021 "Outstanding Innovation in Medical Technology and Life Sciences" of High-Tech Awards by Octane. The Company has been invited to various national and international conferences, published its studies, listed among the Top 10 MedTech Startups, and featured in ABC7, Fortune, BBC, and Nature Medicine. Seed / Dec 01, 2021
Leo Cancer Care Leo Cancer Care
Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position. The company designs integrated imaging, patient positioning, and treatment systems that are compatible with fixed radiation beam platforms used in photon and particle therapy. Its technology focuses on supporting the radiotherapyworkflow from patient simulation through treatment while enabling multiple radiation therapy modalities. Leo Cancer Care also collaborates with healthcare providers, research institutions, and industry partners to evaluate and advance the clinical use of upright radiotherapy systems. In addition to developing treatment technologies, the company works on expanding access to radiotherapy through solutions that aim to improve workflow efficiency and compatibility with existing treatment infrastructure. $25.3M / Series B / Jul 20, 2021
See all 11 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Beauty
Fashion
Medical
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Web3
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Recruiting
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Tunisia
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Taiwan
Zimbabwe
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Ghana
Denmark
Georgia
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Kenya
Saudi Arabia
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Hungary
Italy
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Device of Tomorrow Capital invest in?

Device of Tomorrow Capital invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Device of Tomorrow Capital last invest?

The most recent investment recorded for Device of Tomorrow Capital closed in Dec 2025. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Device of Tomorrow Capital Find emails